In a recent article, Frolov et al. (2002) stated that only five somatic mutations in BRCA1 have been identified in sporadic ovarian carcinomas (Hosking et al., 1995;Merajver et al., 1995) and that only one case of clear cell carcinoma had been reported to be associated with BRCA1 mutations (Hartley
BRCA1mutations and phenotype
✍ Scribed by K. Grade; K. Höffken; R. Kath; A. Nothnagel; E. Bender; S. Scherneck
- Publisher
- Springer-Verlag
- Year
- 1997
- Tongue
- English
- Weight
- 208 KB
- Volume
- 123
- Category
- Article
- ISSN
- 1432-1335
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
## RESULTS. BRCA1 is an estrogen-inducable cell cycle-associated protein with antiproliferation and tumor suppressor function. Less is known about BRCA2 protein 1 Department of Pathology, St. Luke's Hospital, but it has some similarities to BRCA1. Release of cells from BRCA1 control through Chester
Hereditary breast carcinomas constitute about 10% of all malignant mammary tumors, but the selection criteria to identify a high-risk population carrying BRCA1 mutations are not yet well-defined. We have collected 51 pedigrees of familial breast cancer, 16 pedigrees of familial breast and ovarian ca
We have screened index cases from 25 Russian breast/ovarian cancer families for germ-line mutations in all coding exons of the BRCA1 and BRCA2 genes, using multiplex heteroduplex analysis. In addition we tested 22 patients with breast cancer diagnosed before age 40 without family history and 6 patie